Cyclosporine or methotrexate, which one is more promising in the treatment of lichen planopilaris?; A comparative clinical trial

Farahnaz Fatemi Naeini, Fatemeh Mohaghegh, Minoo Jelvan, Ali Asilian, Mina Saber

Open source

DOI
10.1016/j.intimp.2020.106765
Published
2020-09
Container
International Immunopharmacology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.intimp.2020.106765,
  title = {Cyclosporine or methotrexate, which one is more promising in the treatment of lichen planopilaris?; A comparative clinical trial},
  author = {Farahnaz Fatemi Naeini and Fatemeh Mohaghegh and Minoo Jelvan and Ali Asilian and Mina Saber},
  year = {2020},
  journal = {International Immunopharmacology},
  doi = {10.1016/j.intimp.2020.106765},
  url = {https://doi.org/10.1016/j.intimp.2020.106765}
}

RIS

TY  - JOUR
TI  - Cyclosporine or methotrexate, which one is more promising in the treatment of lichen planopilaris?; A comparative clinical trial
AU  - Farahnaz Fatemi Naeini
AU  - Fatemeh Mohaghegh
AU  - Minoo Jelvan
AU  - Ali Asilian
AU  - Mina Saber
PY  - 2020
JO  - International Immunopharmacology
DO  - 10.1016/j.intimp.2020.106765
UR  - https://doi.org/10.1016/j.intimp.2020.106765
ER  - 

APA

Naeini, F. F., Mohaghegh, F., Jelvan, M., Asilian, A., & Saber, M. (2020). Cyclosporine or methotrexate, which one is more promising in the treatment of lichen planopilaris?; A comparative clinical trial. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2020.106765

Source records